ArticleTrials2022

Xanthohumol microbiome and signature in adults with Crohn's disease (the XMaS trial): a protocol for a phase II triple-masked, placebo-controlled clinical trial.

Blake O Langley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.